Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38819031

Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Oct 10
First author
Solomon BJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2024 Oct 10;42(29):3383-3386. doi: 10.1200/JCO.24.01147.
    note
    Source null
    related pmid
    39231392
    relationship
    Comment in
  2. citation
    Transl Lung Cancer Res. 2025 Jan 24;14(1):1-6. doi: 10.21037/tlcr-24-903.
    note
    Source null
    related pmid
    39958226
    relationship
    Comment in

Authors and identifiers

  1. name
    Solomon BJ
    type
    Author
  2. name
    Liu G
    type
    Author
  3. name
    Felip E
    type
    Author
  4. name
    Mok TSK
    type
    Author
  5. name
    Soo RA
    type
    Author
  6. name
    Mazieres J
    type
    Author
  7. name
    Shaw AT
    type
    Author
  8. name
    de Marinis F
    type
    Author
  9. name
    Goto Y
    type
    Author
  10. name
    Wu YL
    type
    Author
  11. name
    Kim DW
    type
    Author
  12. name
    Martini JF
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Solomon BJ
    type
    Author
  2. name
    Liu G
    type
    Author
  3. name
    Felip E
    type
    Author
  4. name
    Mok TSK
    type
    Author
  5. name
    Soo RA
    type
    Author
  6. name
    Mazieres J
    type
    Author
  7. name
    Shaw AT
    type
    Author
  8. name
    de Marinis F
    type
    Author
  9. name
    Goto Y
    type
    Author
  10. name
    Wu YL
    type
    Author
  11. name
    Kim DW
    type
    Author
  12. name
    Martini JF
    type
    Author
bibliography ids
  1. nci-bib-3a47e1b38b31d57faa9455cf
book metadata
content sha256
0fd99097c8b5c478b45eacdb9bc082ee38b3aad3d37df23087176d6cdcdd31b1
document type
citation
dois
  1. 10.1200/JCO.24.00581
electronic publication date
display
2024 May 31
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:38819031
immutable id
pubmed:38819031@0fd99097c8b5c478b45eacdb9bc082ee38b3aad3d37df23087176d6cdcdd31b1
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
29
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3400-3409
volume
42
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2024 Oct 10;42(29):3383-3386. doi: 10.1200/JCO.24.01147.
    note
    Source null
    related pmid
    39231392
    relationship
    Comment in
  2. citation
    Transl Lung Cancer Res. 2025 Jan 24;14(1):1-6. doi: 10.21037/tlcr-24-903.
    note
    Source null
    related pmid
    39958226
    relationship
    Comment in
outcomes validated
false
pmid
38819031
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
97fbc1ee7d60885373ff6261d8edce44d929c740caab001afb5073a3234fec37
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Oct 10
precision
day
year
2024
publication types
  1. Journal Article
  2. Clinical Trial, Phase III
  3. Randomized Controlled Trial
  4. Comparative Study
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38819031/
title
Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study.

Preserved source evidence · Not medical advice